A Phase 1, Open-Label Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of NBI-98854 in Healthy Subjects
Latest Information Update: 11 Sep 2013
At a glance
- Drugs Valbenazine (Primary) ; Ketoconazole
- Indications Drug-induced dyskinesia; Gilles de la Tourette's syndrome; Schizophrenia
- Focus Adverse reactions; Pharmacokinetics
- 05 Aug 2013 New trial record
- 01 Aug 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.